AI assistant
Sending…
Nykode Therapeutics ASA — Share Issue/Capital Change 2021
Sep 7, 2021
3695_rns_2021-09-07_0d44942c-0d7e-498d-9c83-0ab7e07a6faa.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Share capital increase from exercise of warrants
Share capital increase from exercise of warrants
As a consequence of exercise of 467,864 warrants in Vaccibody AS, the share capital of Vaccibody AS has increased by NOK 4,678.64 from NOK 2,865,438.45 to NOK 2,870,117.09. The number of outstanding shares in the company has increased by 467,864 from 286,543,845 to 287,011,709, each with a par value of NOK 0.01. The warrants were exercised by an employee at a strike price of NOK 2.50 per share.
More from Nykode Therapeutics ASA
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Investor Presentation
2026
Apr 30
Investor Presentation
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 21
AGM Information
2026
Apr 21